Loading...
Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians
BACKGROUND: Limited treatment information is available when patients present with psychotic symptoms secondary to synthetic cannabinoid (SC) use. Symptoms associated with use are often indistinguishable from those encountered with a primary mental illness and also include aggression, confusion, and...
Na minha lista:
| Udgivet i: | Ment Health Clin |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007529/ https://ncbi.nlm.nih.gov/pubmed/29955515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.07.156 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|